Sr. Scientist, Data Science
SERVIER MONDE
Summary
We are searching for a talented bioinformatics Senior Scientist to join our Data Science team. The Senior Scientist will be performing Next Generation Sequencing (NGS) data analysis and interpretation for multiple Oncology programs. This individual will be integrated with program teams, contributing to study design, data analysis, and internal / external communication of results. The candidate is expected to drive projects by translating bioinformatics analysis results into biological insights and testable hypotheses.
Job description
Role Summary
We are searching for a talented bioinformatics Senior Scientist to join our Data Science team. The Senior Scientist will be performing Next Generation Sequencing (NGS) data analysis and interpretation for multiple Oncology programs. This individual will be integrated with program teams, contributing to study design, data analysis, and internal / external communication of results. The candidate is expected to drive projects by translating bioinformatics analysis results into biological insights and testable hypotheses.
Primary Responsibilities
- Design, analyse, and interpret genomic studies in Exploratory and Clinical Oncology programs at Servier.
- Work closely with cross-functional program team members to think deeply about novel target biology and drugging strategy.
- Address key biological questions using available genomic data.
- Propose new experiments based on analysis results.
- Use public and proprietary NGS data to identify novel cancer targets, patient selection hypotheses, and combination treatment strategies.
- Conduct analyses of NGS data, including analysis workflow development (WDL / CWL / Nextflow), new method implementation and assessment, and data visualization and interpretation.
- Deliver scientific presentations and publications.
Education and Required Skills
- Ph.D. in Computational Biology, Biology, Statistics, or a related field, with at least 5 years of working experience in Drug Discovery and/or Translational setting, preferably in Oncology.
- Publication track record demonstrating ability to translate Bioinformatics analysis results into new biological insights.
- Expertise in processing and analysis of next-generation sequencing data (RNA, DNA, DNA methylation).
- Familiarity with TCGA and other publicly available oncology datasets, cell line and in vivo shRNA/CRISPR screening.
- Strong hands-on programming skills: especially R/Bioconductor, Python, SQL, Unix & cluster computing environment.
- Experience with data visualization tools (ggplot2, RStudio Connect/Shiny).
- Excellent cross-functional communication skills.
- Strong organizational skills; self-motivated and able to work independently or in a small team.
Travel and Location
- This employee will be based in Boston, MA and will be expected to work in the office at least 3 times a week.
Requirements
- Ph.D. in Computational Biology, Biology, Statistics, or a related field
- At least 5 years of working experience in Drug Discovery and/or Translational setting, preferably in Oncology
- Publication track record demonstrating ability to translate Bioinformatics analysis results into new biological insights
- Expertise in processing and analysis of next-generation sequencing data (RNA, DNA, DNA methylation)
- Familiarity with TCGA and other publicly available oncology datasets, cell line and in vivo shRNA/CRISPR screening
- Strong hands-on programming skills: especially R/Bioconductor, Python, SQL, Unix & cluster computing environment
- Experience with data visualization tools (ggplot2, RStudio Connect/Shiny)
- Excellent cross-functional communication skills
- Strong organizational skills; self-motivated and able to work independently or in a small team
Benefits
- Medical, Dental & Vision
- Flexible time off
- Unlimited sick time
- 401(k)
- Life insurance
- Disability insurance
- Recognition programs
- Short-Term Incentive
- Long-Term Incentive
Company overview
Servier, officially known as Laboratoires Servier, is a leading international pharmaceutical company founded in 1954 and headquartered in Suresnes, France. As the second largest French pharmaceutical group and the leading independent French pharmaceutical company, Servier operates in close to 140 countries worldwide, with 82% of its sales generated outside France. The company specializes in three main therapeutic areas: oncology, cardiometabolism & venous diseases, and neurology, with a particular focus on becoming a significant player in oncology, especially for rare cancers. Servier is governed by a unique non-profit foundation model that preserves its independence and allows for long-term strategic vision. The company invests approximately 20% of its brand-name medicine revenue into research and development annually, employing over 22,000 people globally, including 3,000 dedicated to R&D. With revenue of €5.9 billion in 2023/2024, Servier maintains 13 production sites and 6 research centers worldwide, producing 95.8% of active ingredients for its brand-name medicines in France. The company has established itself as a world leader in cardiology and hypertension treatments while expanding its oncology portfolio through strategic acquisitions and partnerships.